Evidence map›Paper›PMID 34255720›Full record

ArticleJMIR research protocols2021

Investigating the Mechanisms of Graded Sensorimotor Precision Training in Adults With Chronic Nonspecific Low Back Pain: Protocol for a Causal Mediation Analysis of the RESOLVE Trial.

Aidan G Cashin, Hopin Lee, Matthew K Bagg, Benedict M Wand, Edel O'Hagan, Rodrigo R N Rizzo, Tasha R Stanton, G Lorimer Moseley, James H McAuley

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Aidan G CashinPrince of Wales Clinical School, University of New South Wales, Randwick, Australia.ORCID https://orcid.org/0000-0003-4190-7912
Hopin LeeOxford Clinical Trials Research Unit and Centre for Statistics in Medicine, Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0001-5692-0314
Matthew K BaggPrince of Wales Clinical School, University of New South Wales, Randwick, Australia.ORCID https://orcid.org/0000-0002-4812-3814
Benedict M WandSchool of Physiotherapy, The University of Notre Dame, Fremantle, Australia.ORCID https://orcid.org/0000-0002-0297-0292
Edel O'HaganPrince of Wales Clinical School, University of New South Wales, Randwick, Australia.ORCID https://orcid.org/0000-0002-1914-5918
Rodrigo R N RizzoCentre for Pain IMPACT, Neuroscience Research Australia, Sydney, Australia.ORCID https://orcid.org/0000-0002-9624-6210
Tasha R StantonIIMPACT in Health, University of South Australia, Adelaide, Australia.ORCID https://orcid.org/0000-0001-7106-4456
G Lorimer MoseleyIIMPACT in Health, University of South Australia, Adelaide, Australia.ORCID https://orcid.org/0000-0002-3750-4945
James H McAuleyCentre for Pain IMPACT, Neuroscience Research Australia, Sydney, Australia.ORCID https://orcid.org/0000-0002-0550-828X
UNSW Sydney · AUUniversity of South Australia · AUNuffield Orthopaedic Centre · GBThe University of Notre Dame Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic low back pain (CLBP) is a global health problem associated with an increasing burden on individuals, health care systems, and society. Common treatments for people with CLBP produce, on average, small short-term improvements in pain and function compared with minimal care. The RESOLVE trial randomly allocated 276 people with CLBP to a new complex treatment strategy, pain education integrated with graded sensorimotor precision training (RESOLVE), or a sham control. The RESOLVE treatment was developed within a theoretical framework to target possible treatment mechanisms associated with CLBP development and persistence.

objectiveThis protocol describes the planned evaluation of these proposed treatment mechanisms. Improved understanding of the mechanisms underpinning the RESOLVE treatment may guide its refinement and implementation.

methodsWe will use causal mediation analysis to evaluate the proposed treatment mechanisms, including pain self-efficacy, back beliefs, pain catastrophizing, kinesiophobia, back perception, tactile acuity, and movement coordination. The primary outcomes are pain intensity and function at 18 weeks following allocation. Data were collected blind to allocation and hypotheses at baseline (mediators, outcomes, confounders), end of treatment (mediators), and at 18 weeks following allocation (outcomes). We will test the robustness of our findings by conducting planned sensitivity analyses.

resultsEthical approval was granted by the University of New South Wales Human Research Ethics Committee (HC15357). A total of 276 participants have been recruited from primary care practices and the community in Sydney, Australia.

conclusionsThe RESOLVE treatment constitutes a new paradigm for CLBP management with potentially wide-reaching implications. This mechanistic evaluation will provide evidence for the hypothesized treatment mechanisms and help explain why the treatment strategy did or did not have an effect on patient-reported outcomes. These results will help guide the treatment refinement and implementation.

trial registrationAustralian and New Zealand Clinical Trials Registry ACTRN12615000610538; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=368619&isReview=true. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/26053.

Indexed as

chronic low back painmechanism evaluationmediation analysisprotocol

Identifiers

PMID34255720
PMCPMC8285749
OpenAlexW3177482177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.